Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combining docking and molecular dynamic simulations in drug design.

Hernán Alonso1, Andrey A Bliznyuk, Jill E Gready

  • 1Computational Proteomics Group, John Curtin School of Medical Research, The Australian National University, Canberra ACT 0200, Australia.

Medicinal Research Reviews
|June 8, 2006
PubMed
Summary

Computer-aided drug design, combining docking and molecular dynamics (MD) simulations, accelerates the discovery of new medicines. These advanced computational methods improve accuracy and efficiency in identifying potential drug candidates for various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kohn-Sham Density Functional Calculations Reveal Proton Wires in the Enolization and Carboxylase Reactions Catalyzed by Rubisco.

The journal of physical chemistry. B·2020
Same author

Response: Commentary: Directions for Optimization of Photosynthetic Carbon Fixation: RuBisCO's Efficiency May Not Be So Constrained After All.

Frontiers in plant science·2019
Same author

Ab Initio Molecular Dynamics Simulation and Energetics of the Ribulose-1,5-biphosphate Carboxylation Reaction Catalyzed by Rubisco: Toward Elucidating the Stereospecific Protonation Mechanism.

The journal of physical chemistry. B·2019
Same author

Revised mechanism of carboxylation of ribulose-1,5-biphosphate by rubisco from large scale quantum chemical calculations.

Journal of computational chemistry·2018
Same author

Directions for Optimization of Photosynthetic Carbon Fixation: RuBisCO's Efficiency May Not Be So Constrained After All.

Frontiers in plant science·2018
Same author

Evolving Methanococcoides burtonii archaeal Rubisco for improved photosynthesis and plant growth.

Scientific reports·2016

Area of Science:

  • Computational chemistry and structural biology
  • Drug discovery and development
  • Bioinformatics and cheminformatics

Background:

  • Genomic and proteomic research continuously identifies novel drug targets.
  • Combinatorial chemistry provides large libraries of small compounds for screening.
  • Computer-aided drug design (CADD) has evolved significantly, improving cost-effectiveness and speed in drug discovery.

Purpose of the Study:

  • To review recent advancements in CADD, focusing on the integration of docking and molecular dynamics (MD) simulations.
  • To critically analyze protocols and applications of these computational methods in drug design.
  • To highlight successes, limitations, and future directions in using CADD for identifying drug candidates.

Main Methods:

  • Utilizing fast docking algorithms for initial screening of large compound libraries.

Related Experiment Videos

  • Employing molecular dynamics (MD) simulations for structure optimization and flexibility analysis of protein receptors.
  • Refining docked complexes with MD to account for solvent effects and induced fit.
  • Calculating binding free energies using MD for accurate ligand ranking.
  • Integrating MD into the docking process for *a priori* binding site identification.

    • Main Results:

    • Combined docking and MD simulations demonstrate significant success in identifying and optimizing drug candidates.
    • MD simulations enhance receptor preparation, ligand refinement, and binding affinity prediction.
    • The integrated approach allows for accurate ranking of potential ligands, reducing the need for extensive experimental validation.
    • Recent developments show MD's capability in *a priori* binding site identification and docking.

    Conclusions:

    • The synergistic use of docking and MD simulations represents a powerful and increasingly reliable strategy in modern drug discovery.
    • These computational tools significantly reduce costs and accelerate the identification of viable drug candidates.
    • Further advancements in algorithms and computational power will continue to enhance the predictive accuracy and applicability of CADD techniques.